COLUMBUS, Ohio--(BUSINESS WIRE)--Battelle and subcontractor CMC Pharmaceuticals announced today their selection by the U.S. Department of Defense (DOD) to develop an improved nerve agent countermeasure to enhance the current standard of care for the warfighter and increase survivability. The contract, awarded through the Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense’s (JPEO-CBRND) Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Medical (JPM CBRN Medical), funds the development of the medical countermeasure through FDA approval and is valued at over $53 million over 6.5 years..

俄亥俄州哥伦布市——（商业新闻短讯）——Battelle及其分包商CMC Pharmaceuticals今天宣布，美国国防部（DOD）将选择开发一种改进的神经毒剂对策，以提高目前对作战人员的护理标准并提高生存能力。该合同由化学、生物、辐射和核防御联合项目执行办公室（JPEO-CBRND）化学、生物、辐射和核医学联合项目经理（JPM CBRN Medical）授予，通过FDA批准为医疗对策的开发提供资金，6.5年内价值超过5300万美元。。

“Battelle has a long history of working with the DOD on protecting military troops from chemical threats,” said Drew Cawthon (Business Line Director). “We’re proud to continue this important work and to develop next-generation solutions with a strong partner like CMC Pharmaceuticals.”

业务部门主管德鲁·卡顿（DrewCawthon）表示：“巴特尔（Battelle）与国防部合作保护军队免受化学威胁的历史悠久。”。“我们很自豪能够继续这项重要的工作，并与CMC Pharmaceuticals等强大的合作伙伴一起开发下一代解决方案。”

Teaming with Battelle as a subcontractor on the program is CMC Pharmaceuticals, an Ohio-based company that will provide the laboratory development, current Good Manufacturing Practice (cGMP) testing, and Contract Manufacturing Organization (CMO) oversight required for all product development activities through U.S.

CMC Pharmaceuticals与Battelle作为该项目的分包商合作，该公司位于俄亥俄州，将通过美国提供所有产品开发活动所需的实验室开发、当前良好生产规范（cGMP）测试和合同制造组织（CMO）监督。

Food and Drug Administration (FDA) approval..

美国食品和药物管理局（FDA）批准。。

“Our expertise and vast breadth of knowledge in drug product development and manufacturing is a crucial component of this important program,” said Mike Radomsky, President of CMC Pharmaceuticals. “We are excited to begin work with Battelle and the DOD on this program and are honored that our team will help deliver an improved therapeutic to our troops against the threat of nerve agents.”.

CMC Pharmaceuticals总裁迈克·拉多姆斯基（MikeRadomsky）表示：“我们在药品开发和制造方面的专业知识和广博知识是这一重要项目的重要组成部分。“我们很高兴能开始与巴特尔和国防部在这个项目上的合作，我们的团队将帮助我们的部队提供改进的治疗方法，以对抗神经毒剂的威胁，我们对此感到荣幸。”。

The program aims to develop the Reactivating Nerve Agent Treatment System (RNATS), an improved reactivator in a vial, intended for use by the U.S. military and allies to counteract chemical threats, specifically nerve agents. Reactivator compounds counteract the effects of nerve agents by ‘reactivating’ the acetylcholinesterase (AChE) enzyme..

该项目旨在开发再激活神经毒剂治疗系统（RNATS），这是一种改进的小瓶再激活剂，旨在供美国军方和盟国用于应对化学威胁，特别是神经毒剂。再激活剂化合物通过“再激活”乙酰胆碱酯酶（AChE）酶来抵消神经毒剂的作用。。

About Battelle

关于巴特尔

Every day, the people of Battelle apply science and technology to solving what matters most. At major technology centers and national laboratories around the world, Battelle conducts research and development, designs and manufactures products, and delivers critical services for government and commercial customers.

巴特尔的人们每天都在应用科学技术来解决最重要的问题。在世界各地的主要技术中心和国家实验室，巴特尔进行研究和开发，设计和制造产品，并为政府和商业客户提供关键服务。

Headquartered in Columbus, Ohio since its founding in 1929, Battelle serves the national security, health and life sciences, and energy and environmental industries. For more information, visit www.battelle.org..

巴特尔自1929年成立以来，总部位于俄亥俄州哥伦布，服务于国家安全、健康和生命科学以及能源和环境行业。有关更多信息，请访问www.battelle.org。。

About CMC Pharmaceuticals

关于CMC Pharmaceuticals

CMC Pharmaceuticals is a leading provider of drug product development services and manufacturing support to the pharmaceutical and biotechnology industries. Located in Solon, Ohio, CMC Pharmaceuticals delivers specialized scientific expertise and services including pre-formulation, formulation development, analytical development, cGMP lab services, stability and compatibility studies, manufacturing process development, CMO oversight, and consulting services to clients globally.

CMC Pharmaceuticals是为制药和生物技术行业提供药品开发服务和制造支持的领先供应商。CMC Pharmaceuticals位于俄亥俄州梭伦市，为全球客户提供专业的科学专业知识和服务，包括预配方、配方开发、分析开发、cGMP实验室服务、稳定性和兼容性研究、制造工艺开发、CMO监督和咨询服务。

Decades of specialized scientific experience in the development and manufacture of a wide range of drug product types including sterile injectables, solid oral, long-acting, controlled release, and other complex dosage forms. CMC Pharma has successfully managed a wide variety of pharmaceutical development programs, including multi-year programs with the federal government.

在开发和制造各种药物产品类型方面拥有数十年的专业科学经验，包括无菌注射剂，固体口服，长效，控释和其他复杂剂型。CMC Pharma已成功管理了多种药物开发计划，包括与联邦政府合作的多年计划。

For more information, visit www.cmcpharm.com..

有关更多信息，请访问www.cmcpharm.com。。